GlassScriptPhysician profile
Winston Chung
NPI 1851322085
$1,419.75
in general payments reported to CMS, 2019-2025
23 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $98.35 · 2021: $161 · 2022: $162 · 2023: $297 · 2024: $99.29 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $251.44 | 2019-2021 | |
| Abbvie INC. | $130.29 | 2021-2023 | Teflaro |
| Alkermes, INC. | $117.63 | 2019 | |
| Karyopharm Therapeutics INC. | $108.03 | 2023 | Xpovio |
| Merck Sharp & Dohme LLC | $94.83 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Electromed, INC. | $80.27 | 2023-2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $79.27 | 2024-2025 | |
| Gilead Sciences, INC. | $62.19 | 2021-2022 | |
| Lilly USA, LLC | $61.48 | 2022-2023 | Mounjaro |
| Allergan, INC. | $51.24 | 2020 | |
| Novo Nordisk INC | $47.76 | 2022-2023 | Ozempic |
| Glaxosmithkline, LLC. | $46.49 | 2023 | Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $46.48 | 2019-2023 | Jynarque |
| Amgen INC. | $41.82 | 2024-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $32.43 | 2025 | Farxiga |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29.66 | 2025 | Freestyle Libre 3 |
| Abiomed | $27.82 | 2025 | |
| Pfizer INC. | $23.37 | 2025 | |
| Sun Pharmaceutical Industries INC. | $22.17 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.87 | 2022 | |
| Lundbeck LLC | $18.05 | 2025 | Rexulti |
| Exact Sciences Corporation | $17.29 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.